Details of the Drug Formulaction

General Information of Drug Formulation (ID: F21765)

• Formulation Name: Ursodeoxycholic acid 500 mg tablet
• Company: Actavis Pharma; BluePoint Laboratories; Lake Eire Medical & Surgical Supply DBA Quality Care Products

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ursodeoxycholic acid	(DMCUT21)	Cholelithiasis	DC11	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Polyethylene glycol 400	(E00653)	Not Available	Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent